<?xml version="1.0" encoding="UTF-8"?><CodeSystem xmlns="http://hl7.org/fhir"><id value="v3-substanceAdminSubstitution"/><meta><lastUpdated value="2016-03-23T00:00:00.000+00:00"/></meta><text><status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p>Release Date: 2016-03-23</p>
<table class="grid">
 <tr><td><b>Level</b></td><td><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr>
 <tr><td>1</td><td><span style="color: grey"><i>(_ActSubstanceAdminSubstitutionCode)</i></span> <b><i>Abstract</i></b></td><td><a name="_ActSubstanceAdminSubstitutionCode"> </a></td><td>
                        
                           Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.<br/>

                     </td></tr>
 <tr><td>2</td><td>  E<a name="E"> </a></td><td>equivalent</td><td>
                        
                           Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.<br/>

                     </td></tr>
 <tr><td>3</td><td>    EC<a name="EC"> </a></td><td>equivalent composition</td><td>
                        
                           Description: 
                        <br/>

                        Substitution occurred or is permitted with another product that is a:<br/>

                        
                           pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
                           pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
                        
                        
                           Examples: 
                        <br/>

                        
                           
                              Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
                           
                              Pharmaceutical equivalent: Lisonpril for Zestril
                        
                     </td></tr>
 <tr><td>4</td><td>      BC<a name="BC"> </a></td><td>brand composition</td><td>
                        
                           Description: 
                        <br/>

                        Substitution occurred or is permitted between equivalent Brands but not Generics<br/>

                        
                           Examples: 
                        <br/>

                        
                           Zestril  for Prinivil
                           Coumadin for Jantoven
                        
                     </td></tr>
 <tr><td>4</td><td>      G<a name="G"> </a></td><td>generic composition</td><td>
                        
                           Description: Substitution occurred or is permitted between equivalent Generics but not Brands<br/>

                        
                           Examples: 
                        <br/>

                        
                           Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
                        
                     </td></tr>
 <tr><td>3</td><td>    TE<a name="TE"> </a></td><td>therapeutic alternative</td><td>
                        
                           Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.<br/>

                        
                           Examples: 
                        <br/>

                        
                           ranitidine for Tagamet
                        
                     </td></tr>
 <tr><td>4</td><td>      TB<a name="TB"> </a></td><td>therapeutic brand</td><td>
                        
                           Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics<br/>
&gt;
                           Examples: 
                        <br/>

                        
                           Zantac for Tagamet
                        
                     </td></tr>
 <tr><td>4</td><td>      TG<a name="TG"> </a></td><td>therapeutic generic</td><td>
                        
                           Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands<br/>
&gt;
                           Examples: 
                        <br/>

                        
                           Ranitidine  for cimetidine
                        
                     </td></tr>
 <tr><td>2</td><td>  F<a name="F"> </a></td><td>formulary</td><td>
                        
                           Description: This substitution was performed or is permitted based on formulary guidelines. <br/>

                     </td></tr>
 <tr><td>2</td><td>  N<a name="N"> </a></td><td>none</td><td>
                        No substitution occurred or is permitted.<br/>

                     </td></tr>
</table>
</div></text><url value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/><identifier><system value="urn:ietf:rfc:3986"/><value value="urn:oid:2.16.840.1.113883.5.1070"/></identifier><version value="2016-03-23"/><name value="v3 Code System substanceAdminSubstitution"/><status value="active"/><experimental value="false"/><publisher value="HL7, Inc"/><contact><telecom><system value="other"/><value value="http://hl7.org"/></telecom></contact><date value="2016-03-23T00:00:00+00:00"/><description value=" Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided."/><caseSensitive value="true"/><valueSet value="http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution"/><hierarchyMeaning value="subsumes"/><content value="complete"/><property><code value="notSelectable"/><uri value="http://hl7.org/fhir/concept-properties#notSelectable"/><description value="Indicates that the code is abstract - only intended to be used as a selector for other concepts"/><type value="boolean"/></property><concept><code value="_ActSubstanceAdminSubstitutionCode"/><display value="ActSubstanceAdminSubstitutionCode"/><definition value="Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects."/><property><code value="notSelectable"/><valueBoolean value="true"/></property><concept><code value="E"/><display value="equivalent"/><definition value="Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product."/><concept><code value="EC"/><display value="equivalent composition"/><definition value="Description: 
                        

                        Substitution occurred or is permitted with another product that is a:

                        
                           pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
                           pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
                        
                        
                           Examples: 
                        

                        
                           
                              Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
                           
                              Pharmaceutical equivalent: Lisonpril for Zestril"/><concept><code value="BC"/><display value="brand composition"/><definition value="Description: 
                        

                        Substitution occurred or is permitted between equivalent Brands but not Generics

                        
                           Examples: 
                        

                        
                           Zestril  for Prinivil
                           Coumadin for Jantoven"/></concept><concept><code value="G"/><display value="generic composition"/><definition value="Description: Substitution occurred or is permitted between equivalent Generics but not Brands

                        
                           Examples: 
                        

                        
                           Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)"/></concept></concept><concept><code value="TE"/><display value="therapeutic alternative"/><definition value="Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

                        
                           Examples: 
                        

                        
                           ranitidine for Tagamet"/><concept><code value="TB"/><display value="therapeutic brand"/><definition value="Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics
&gt;
                           Examples: 
                        

                        
                           Zantac for Tagamet"/></concept><concept><code value="TG"/><display value="therapeutic generic"/><definition value="Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands
&gt;
                           Examples: 
                        

                        
                           Ranitidine  for cimetidine"/></concept></concept></concept><concept><code value="F"/><display value="formulary"/><definition value="Description: This substitution was performed or is permitted based on formulary guidelines."/></concept><concept><code value="N"/><display value="none"/><definition value="No substitution occurred or is permitted."/></concept></concept></CodeSystem>